共 55 条
- [1] Green WR(1981)Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases Retina 1 27-55
- [2] Chan CC(2008)Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator Mol Ther 16 791-799
- [3] Hutchins GM(2010)Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 e1-1032
- [4] Terry JM(2012)Vascular endothelial growth factor trap-eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study Ophthalmology 119 1024-2087
- [5] Campochiaro PA(2010)Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion Ophthalmology 117 e3-809
- [6] Hafiz G(2017)Effect of bevacizumab vs aflibercept on visual acuity among patients with macular edema due to central retinal vein occlusion: the SCORE2 randomized clinical trial JAMA 317 2072-219
- [7] Shah SM(2012)Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial Ophthalmology 119 802-1038
- [8] Brown DM(2014)Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study Ophthalmology 121 209-133
- [9] Campochiaro PA(2014)Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study Ophthalmology 121 e1-142
- [10] Singh RP(2014)Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study Am J Ophthalmol 158 1032-59